Related references
Note: Only part of the references are listed.Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
Xilin Yang et al.
DIABETES (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
Krisztina Kisfalvi et al.
CANCER RESEARCH (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Insulin Glargine and Cancer-An Unsubstantiated Allegation
Satish K. Garg et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2009)
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
J. Rosenstock et al.
DIABETOLOGIA (2009)
Does diabetes therapy influence the risk of cancer?
U. Smith et al.
DIABETOLOGIA (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis
A. Dejgaard et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens et al.
DIABETOLOGIA (2009)
Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines
Ashish Shukla et al.
ENDOCRINE-RELATED CANCER (2009)
Do Diabetes Drugs Modify the Risk of Pancreatic Cancer?
Yu-Xiao Yang
GASTROENTEROLOGY (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: A systematic review and meta-analysis
Chun Chao et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Cancer as an endocrine problem
Jeff M. P. Holly et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Diabetes and Risk of Non-Hodgkin's Lymphoma A meta-analysis of observational studies
Joanna Mitri et al.
DIABETES CARE (2008)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Walter H. Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Proliferative effects of insulin analogues on mammary epithelial cells
Doris Mayer et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
E. Friberg et al.
DIABETOLOGIA (2007)
The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas
Edward Govannucci et al.
GASTROENTEROLOGY (2007)
Diabetes mellitus and risk of bladder cancer: a meta-analysis
S. C. Larsson et al.
DIABETOLOGIA (2006)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Diabetes mellitus and risk of colorectal cancer: A meta-analysis
SC Larsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
A prospective study of C-peptide, insulin-like growth factor-1, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women
EK Wei et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Fasting serum glucose level and cancer risk in Korean men and women
SH Jee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice
I Stammberger et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2002)
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
P Kurtzhals et al.
DIABETES (2000)
Share Paper
